News
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Adding polatuzumab vedotin to rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved overall survival in transplant-ineligible patients with relapsed/refractory diffuse large B-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results